Aktive Positionen von Michael Mullette
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Lykos Therapeutics PBC
 Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Geschäftsführer | 01.03.2022 | - |
Karriereverlauf von Michael Mullette
Ehemalige bekannte Positionen von Michael Mullette
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MODERNA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Health Technology |
- Börse
- Insiders
- Michael Mullette
- Erfahrung
